Imagilin Attends FASAVA in Tokyo, Japan
On September 27 - September 29, 2019 Imagilin® Technology attended FASAVA/JBVP in Tokyo, Japan. There, Imagilin® Technology gave two...
On September 27 - September 29, 2019 Imagilin® Technology attended FASAVA/JBVP in Tokyo, Japan. There, Imagilin® Technology gave two...
Helps Reduce Digestive Disorders and Boost Immune Activity On April 29, 2019, Dr. J.J. Lin, chief scientist of Imagilin® Technology, LLC,...
A recent study led by John H. Curtis, part of Dr. Brian McFarlin’s research group (FACSM) at the University of North Texas, was published...
Information of a new plant-based, non-spore forming probiotic, PA5051®, was presented by Dr. J.J. Lin, chief scientist of Imagilin...
A new pilot study recently published in CDN (Current Developments In Nutrition) concluded that Pediococcus acidilactici NRRL B-50517...
May 17, 2018 Dr. Lin and Joshua Lin are attending SIAL CHINA 2018 with the Southern United State Trade Association to educate on our...